These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 32422529)

  • 21. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases.
    Guijarro-Castro C; Rosón-González M; Abreu A; García-Arratibel A; Ochoa-Mulas M
    Neurologia (Engl Ed); 2020; 35(6):412-415. PubMed ID: 32565036
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
    Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
    Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barré Syndrome in a Patient With Minimal Symptoms of COVID-19 Infection.
    Oguz-Akarsu E; Ozpar R; Mirzayev H; Acet-Ozturk NA; Hakyemez B; Ediger D; Karli N;
    Muscle Nerve; 2020 Sep; 62(3):E54-E57. PubMed ID: 32497292
    [No Abstract]   [Full Text] [Related]  

  • 25. Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection.
    Naddaf E; Laughlin RS; Klein CJ; Toledano M; Theel ES; Binnicker MJ; Nagappan V; Abdulrazzak M; Phelan DM
    Mayo Clin Proc; 2020 Aug; 95(8):1799-1801. PubMed ID: 32753154
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
    Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
    Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Velayos Galán A; Del Saz Saucedo P; Peinado Postigo F; Botia Paniagua E
    Neurologia (Engl Ed); 2020 May; 35(4):268-269. PubMed ID: 32364123
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.
    Tard C; Maurage CA; de Paula AM; Cassim F; Delval A; Kuchcinski G; Davion JB; Defebvre L; Bouchiba M; ; Jourdain M; Boucraut J
    Neurophysiol Clin; 2020 Oct; 50(5):397-399. PubMed ID: 33190687
    [No Abstract]   [Full Text] [Related]  

  • 31. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
    Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
    Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain Barre syndrome associated with COVID-19 infection: A case report.
    Sedaghat Z; Karimi N
    J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is COVID-19-related Guillain-Barré syndrome different?
    Gupta A; Paliwal VK; Garg RK
    Brain Behav Immun; 2020 Jul; 87():177-178. PubMed ID: 32445789
    [No Abstract]   [Full Text] [Related]  

  • 34. Guillain-Barré syndrome related to SARS-CoV-2 infection.
    Bigaut K; Mallaret M; Baloglu S; Nemoz B; Morand P; Baicry F; Godon A; Voulleminot P; Kremer L; Chanson JB; de Seze J
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32461235
    [No Abstract]   [Full Text] [Related]  

  • 35. Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review.
    Trujillo Gittermann LM; Valenzuela Feris SN; von Oetinger Giacoman A
    Neurologia (Engl Ed); 2020; 35(9):646-654. PubMed ID: 32896460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK.
    Tiet MY; AlShaikh N
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and Guillain-Barré syndrome.
    Joob B; Wiwanitkit V
    Rev Neurol (Paris); 2020 Sep; 176(7):637. PubMed ID: 32410748
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute Motor Axonal Neuropathy Related to COVID-19 Infection: A New Diagnostic Overview.
    Petrelli C; Scendoni R; Paglioriti M; Logullo FO
    J Clin Neuromuscul Dis; 2020 Dec; 22(2):120-121. PubMed ID: 33214404
    [No Abstract]   [Full Text] [Related]  

  • 39. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
    Zhao H; Shen D; Zhou H; Liu J; Chen S
    Lancet Neurol; 2020 May; 19(5):383-384. PubMed ID: 32246917
    [No Abstract]   [Full Text] [Related]  

  • 40. Guillain-Barré syndrome after COVID-19 in Japan.
    Hirayama T; Hongo Y; Kaida K; Kano O
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.